We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
9 hedge funds and large institutions have $182K invested in Plus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.03% less ownership
Funds ownership: 0.12% → 0.09% (-0.03%)
18% less funds holding
Funds holding: 11 → 9 (-2)
27% less capital invested
Capital invested by funds: $247K → $182K (-$65.6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.29K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.27K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$30.2K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$25.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$15.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.9K |